- CRS Publications
- News
News
Authors:
Date:
Business Wire: July 20, 2017 – WILMINGTON, DE, U.S.A. – Personalized cancer therapies are on the horizon thanks to a new genomic cancer research partnership between the Gene Editing Institute of Christiana Care Health System’s Helen F. Graham Cancer Center & Research Institute and the…
Authors:
Date:
PRNewswire: July 20, 2017 – PRINCETON, NJ, U.S.A., and LUND, Sweden – Braeburn Pharmaceuticals (“Braeburn”) and Camurus (NASDAQ STO: CAMX) today announced the completion of the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the approval of the…
Authors:
Date:
Prof. Jennifer Dressman Joins Certara’s Simcyp Scientific Advisory Board
Business Wire: July 13, 2017 – PRINCETON, NJ, U.S.A. – Certara® , the global leader in model-informed drug development and regulatory science, today announced that Prof. Jennifer B. Dressman, Ph.D., has been appointed to the…
Authors:
Date:
PRNewswire: July 12, 2017 – RALEIGH, NC, U.S.A., and PICKERING, ON, Canada – BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company with a focus in pain management and addiction medicine, and Purdue Pharma (Canada) announce that they have signed an exclusive…
Authors:
Date:
PRNewswire: July 11, 2017 – HIGH POINT, NC, U.S.A. – Axium Pharmaceuticals Inc. (www.axium-pharma.com) is a pharmaceutical company aimed at utilizing drug delivery innovations for developing improved novel formulations and alternative dosage forms of existing biologically active molecules.
Axium…
Authors:
Date:
Business Wire: July 10, 2017 – STRASBOURG, France – Medical technology company Defymed, based in Strasbourg, is pleased to announce the development of ExOlin® , a new insulin delivery device. Targeted at persons suffering from diabetes (type 1 diabetics and some type 2 diabetics) needing to…
